Recaticimab
IIT-I-2025-098
Approved small_molecule active
Quick answer
Recaticimab for STEMI - ST Elevation Myocardial Infarction is a Approved program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The First People's Hospital of Lianyungang
- Indication
- STEMI - ST Elevation Myocardial Infarction
- Phase
- Approved
- Modality
- small_molecule
- Status
- active